1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Elimination Disorders: new trials by email Literature Review of Elimination Disorders trials Research Report on Elimination Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Eluxadoline (Viberzi®) 100 mg Twice Daily on Diarrhea-Associated Fecal Incontinence Eluxadoline 100 mg, Placebo - Fecal Incontinence, Accidental Bowel Leakage | Phase 2 | Withdrawn | University of North Carolina, Chapel Hill | 2019-04-01 | 2019-07-25 |
Diarrhea (1) · Encopresis (1) · Fecal Incontinence (1) · Urinary Incontinence, Urge (1)
Behavior (1) · Behavioral Symptoms (1) · Digestive System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1) · Lower Urinary Tract Symptoms (1) · Male Urogenital Diseases (1) · Mental Disorders (1) · Pathological Conditions, Signs and Symptoms (1) · Rectal Diseases (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1)
Sugars (1) · eluxadoline (1)